Trials to Watch

Trials to watch: CRISPR pipeline accelerates after milestone Casgevy approval

December 2023 marked an important milestone in the life of clustered regularly interspaced short palindromic repeat (CRISPR) therapies after Vertex…

HIV: Three trials to watch in 2024

The year 2023 started with disappointing news for the field of human immunodeficiency virus (HIV) research after Janssen’s Phase III…

Trials to watch: Pipeline Parkinson’s drugs could revolutionise treatment

Last month, a new biomarker for Parkinson’s disease was discovered which showed that it develops even earlier than anticipated. Currently,…